Endo Pharmaceuticals Holdings (ENDP) Misses Q2 EPS by 1c, Revenues Top Expectations
Tweet Send to a Friend
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
